ArticleClinical ophthalmology (Auckland, N.Z.)2022
The Vivity Extended Range of Vision IOL vs the PanOptix Trifocal, ReStor 2.5 Active Focus and ReStor 3.0 Multifocal Lenses: A Comparison of Patient Satisfaction, Visual Disturbances, and Spectacle Independence.
Article in Clinical ophthalmology (Auckland, N.Z.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective Study of Vivity & Vivity Toric IOL in Taiwan: Results and Analysis
Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix Pro
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.
- Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.The Cochrane database of systematic reviews · 2023Pooled it
- Outcomes of Bilateral Implantation of a New Aspheric Hydrophobic Non-Diffractive Extended Depth of Focus IOL with a Mini-Monovision Approach.Clinical ophthalmology (Auckland, N.Z.) · 2025Trial
- Premium Intraocular Lens Implantation After Laser Vision Correction: An Updated Narrative Review of Biometry, IOL Selection, Visual Outcomes, and Clinical Management.Journal of clinical medicine · 2026Review
- Reasons for dissatisfaction after implantation of extended depth-of-focus and trifocal intraocular lenses: a retrospective case series.BMC ophthalmology · 2026Article
- Comparison of visual performance outcomes following PanOptix and symfony ZXR00 intraocular lens implantation using the area under the distance-corrected defocus curve.BMC ophthalmology · 2026Article
- Visual Outcomes with Enhanced Monofocal and Non-Diffractive Extended Depth-of-Field Intraocular Lenses.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical Outcomes Following Bilateral Implantation of TECNIS Odyssey Intraocular Lenses in Japanese Eyes.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- A Retrospective Study: Comparative Visual Performance of Two Non-Diffractive Extended Depth-of-Focus Intraocular Lenses: TECNIS PureSee versus Clareon Vivity.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Satisfaction and Visual Outcomes with a Non-Diffractive EDOF IOL in Post-Myopic LASIK and PRK Patients with High Corneal Spherical Aberration.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- The Science of Pseudoaccommodation and Its Therapeutic Potential.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Early Visual Performance and Subjective Experience After Bilateral Implantation of a Novel Fully Refractive Extended Depth of Focus Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Real-World IOL Performance with Bilateral Plano Outcomes After Cataract Surgery: A Prospective, Comparative Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Polychromatic Virtual Retinal Imaging of Two Extended-Depth-of-Focus Intraocular Lenses.Translational vision science & technology · 2025Article
- One-year outcomes after implantation of an EDOF intraocular lens in patients with cataract.Journal of cataract and refractive surgery · 2025Observational
- Evaluation of Clareon Vivity and PureSee intraocular lenses: optical quality, depth of focus and misalignment effects.Scientific reports · 2025Article
- Assessing the clinical outcomes of a novel EDOF intraocular lens: a functional classification approach.BMC ophthalmology · 2025Article
- The Influence of the Level of Monovision upon Early Outcomes Following the Bilateral Implantation of an Enhanced Monovision Intraocular Lens.Vision (Basel, Switzerland) · 2025Article
- Influence of preoperative variables on the 3-month functional outcomes of the Vivity extended depth-of-focus intraocular lens: a prospective case series.Eye and vision (London, England) · 2025Article
- Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A Meta-Analysis.Ophthalmology and therapy · 2025Article
- Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare patient-reported outcomes (PROs) after intraocular lens (IOL) implantation with the AcrySof IQ Vivity IOL or Vivity Toric IOL to those achieved with other multifocal IOLs. PATIENTS AND
methodsProspective, open-label, multicenter analysis of PROs, including spectacle independence, dysphotopsia, and overall satisfaction among patients who underwent cataract surgery at least 1 month previously with bilateral Vivity or Vivity Toric lenses (n=60). Results were compared to outcomes from two similar prospective studies of bilateral AcrySof IQ PanOptix or PanOptix Toric trifocal IOLs (n = 59), blended AcrySof ReSTOR 2.5/3.0 IOLs (n=72) or bilateral ReSTOR ActiveFocus 2.5 D IOLs with a mini-monovision target [n = 95]).
resultsPatients in the Vivity cohort were significantly less likely to notice glare and halo in dim light (85% "none" or "just a little") compared to PanOptix (69%, p<0.03), 2.5 mini-monovision (75%, p< 0.05) or 2.5/3.0 (71%, p< 0.05) patients. Complete spectacle independence for all visual activities combined (never need glasses) with Vivity was comparable to the mini-monovision and 2.5/3.0 groups (33%, 36%, and 31%, respectively) but significantly lower than in the PanOptix cohort (83%, p < 0.0001). Satisfaction was high across all groups. There were no statistically significant differences in best-corrected visual acuity, and no new safety concerns were reported.
conclusionThe AcrySof IQ Vivity extended depth of focus IOL offers an expanded range of vision and better spectacle independence than has typically been achieved with traditional monofocal IOLs, with high rates of satisfaction and a favorable dysphotopsia profile compared to diffractive multifocal IOLs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.